NEOPHARM CYSTOSTOP SR for urinary tract and kidney health x 30 tabl
CYS T OS T OP ® SR
Read this leaflet carefully before you start taking the preparation.
If you have further questions, ask your doctor.
Contents of the leaflet:
- should I not take CYSTOSTOP ® SR?
CYSTOSTOP ® SR
I. WHAT IS CYSTITIS?
Cystitis is an inflammation of the bladder that is more common in women than men, with 4 out of 5 women suffering from cystitis at least once in their lifetime.
The most common cause of cystitis is the bacterium E. coli. Risk factors for its occurrence are the retention of urine in the bladder, catheterization, pregnancy, inflammation of the genital organs, the use of spermicides, sexual intercourse, hormonal changes, menopause, kidney-stone disease, bacterial infection of the prostate, enlarged prostate in men and other conditions preventing complete emptying of the bladder or acting as a source of infection.
The symptoms of cystitis are easy to recognize and start with discomfort when urinating. Then, the urge to urinate becomes frequent, inefficient and painful, accompanied by pain and burning. The color and smell of the urine can change, and sometimes there is even blood in it.
Delayed diagnosis or incorrect treatment with inappropriate antibiotics can lead to chronic, recurrent cystitis – an extremely distressing condition that is very difficult to treat.
With correct and timely diagnosis, adequate treatment and prophylaxis, cystitis is treatable and its recurrences can be successfully avoided.
II. WHAT IS CYSTOSTOP ® SR?
CYSTOSTOP ® SR is a preparation that has a rapid beneficial effect on the health of the urinary tract (bladder, urethra, ureters) and kidneys.
The tablets of CYSTOSTOP ® SR are manufactured using an innovative technology that allows for a prolonged, gradual release of the ingredients of the preparation. This ensures constant adequate concentrations of the active substances in the body, higher efficiency and easier intake of the preparation.
Each CYSTOSTOP ® SR tablet contains:
- – 500 mg
- γ – 50 mg (preserved combination of standardized dry extract of American cranberry - Vaccinum macrocarpon and standard
darted dry extract of birch leaves - Betulla spp., containing 18 mg of proanthocyanidins type A and proanthocyanidins type B, 3,5,7,3',4'-penta-hydroxy-flavone; 3,7,3',4'-tetra-hydroxy-flavone and epicatechin – (4b
6) – epicatechin – (4b 8, 2b O 7) – epicatechin, flavonoids, terpenes, tannins).
CYSTOSTOP ® SR is a food additive.
III. HOW DOES CYSTOSTOP ® SR WORK AND WHO IS IT FOR?
CYSTOSTOP ® SR has a rapid beneficial effect on the health of the urinary tract and kidneys by maintaining the urine at its physiological levels of purity from bacteria.
D-mannose is excreted unchanged in the urine up to 90 minutes after administration. There, it exerts its rapid, beneficial effect, helping to clean the urinary tract with the act of urination. Only two hours after taking D-mannose, only about 10% of it remains in the body, which necessitates its frequent intake (usually every 2 hours). CYSTOSTOP ® SR extended-release tablets provide a gradual release of D-mannose in the body and its sufficient concentration in the urine. Thanks to this, the effect of D-mannose is even better, and the intake of the preparation is significantly facilitated, being reduced to 3 times a day .
The patented combination BetaVac TM γ consists of a specially created combination of extracts of birch leaves and American blueberry wormwood. Cranberry extract contains biologically active substances - proanthocyanidins, which are emitted in the urine, where they support the beneficial effect of D-mannose. Proanthocyanidins and D-mannose mutually enhance their action, and the effect of their joint application is significantly better than their individual use. The other biologically active substances in BetaVac TM γ support the action of D-mannose and proanthocyanidins, supporting the natural formation of urine and the cleansing of the urinary tract with the act of urination.
The effect of CYSTOSTOP ® SR is fast and felt already in the first hours after taking the preparation.
IV. WHO SHOULD NOT TAKE CYSTOSTOP ® SR?
Do not take CYSTOSTOP ® SR if you have ever had an allergic reaction to any of the product's ingredients.
V. WHAT ARE THE SIDE EFFECTS OF CYSTOSTOP ® SR?
So far, there are no known side effects of the drug and no contraindications for its use. Its tolerability is very good, which allows safe intake for a long period of time. CYSTOSTOP ® SR can be used during pregnancy and breastfeeding, as well as in people with diabetes. It is also suitable for children over 6 years of age, as the dose is determined by a specialist, according to the child's weight.
VI. HOW SHOULD CYSTOSTOP ® SR BE TAKEN?
Take CYSTOSTOP ® SR as early as possible, at the first sign of its need.
CYSTOSTOP ® SR should be taken at least 1 hour before or 2 hours after a meal.
ADMISSION SCHEME :
Five consecutive days — 3 times x 2 tablets, every 6 hours.
VII. STORAGE
Store CYSTOSTOP ® SR in its original packaging at a temperature of up to 25°C, in a dry place, out of direct sunlight and out of the reach of children.
Do not use the preparation after its expiration date or if the integrity of the package is broken.
